FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

766046007: Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor (disorder)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3660598019 Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660599010 Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660600013 Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660601012 Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type II inhibitor en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3660602017 Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type II inhibitor en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3660603010 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukaemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukaemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3660604016 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective hematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3660598019 Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660599010 Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660600013 Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3660601012 Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type II inhibitor en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3660602017 Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type II inhibitor en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3660603010 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukaemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukaemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3660604016 A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective hematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
3451681001000111 Akute myeloische Leukämie und myelodysplastische Syndrome durch Topoisomerase Typ II-Inhibitor de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
908001000172115 leucémie aigüe myéloïde et syndromes myélodysplasiques liés aux inhibiteurs de la topoisomérase II fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
908001000172115 leucémie aigüe myéloïde et syndromes myélodysplasiques liés aux inhibiteurs de la topoisomérase II fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3451681001000111 Akute myeloische Leukämie und myelodysplastische Syndrome durch Topoisomerase Typ II-Inhibitor de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a séquelle false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Associated morphology Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type false Inferred relationship Existential restriction modifier (core metadata concept) 1
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Causative agent (attribute) Topoisomerase inhibitor true Inferred relationship Existential restriction modifier (core metadata concept) 1
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a Complication of chemotherapy (disorder) true Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor After Administration of antineoplastic agent true Inferred relationship Existential restriction modifier (core metadata concept) 2
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Finding site Bone marrow structure true Inferred relationship Existential restriction modifier (core metadata concept) 1
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Due to Administration of antineoplastic agent true Inferred relationship Existential restriction modifier (core metadata concept) 3
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a Complication of procedure false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a Disorder following clinical procedure false Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a Complication of introduction procedure true Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a Hematologic complication of procedure true Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a Neoplastic complication of procedure true Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Is a Therapy-related myelodysplastic syndrome (disorder) true Inferred relationship Existential restriction modifier (core metadata concept)
Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor Associated morphology Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Component annotation with string value reference set (foundation metadata concept)

Back to Start